We are live on
!
Find out more
CC
Cannell & Co Portfolio holdings
AUM
$3.15B
1-Year Est. Return
30.62%
This Fund
S&P 500
This Quarter
Est. Return
-0.35%
1 Year Est. Return
+30.62%
3 Year Est. Return
+51.59%
5 Year Est. Return
+187.25%
10 Year Est. Return
+311.58%
AUM
$3.53B
AUM Growth
+$77.1M
(+2.2%)
Cap. Flow
+$137M
Cap. Flow
% of AUM
3.88%
Top 10 Holdings %
Top 10 Hldgs %
30.93%
Holding
290
New
27
Increased
78
Reduced
89
Closed
20
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Whirlpool
WHR
|
+$83.4M |
| 2 |
Analog Devices
ADI
|
+$72.5M |
| 3 |
CELG
Celgene Corp
CELG
|
+$62.7M |
| 4 |
EQT Corp
EQT
|
+$56.9M |
| 5 |
Goldman Sachs
GS
|
+$56.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Micron Technology
MU
|
+$76.6M |
| 2 |
Gilead Sciences
GILD
|
+$67.5M |
| 3 |
PXD
Pioneer Natural Resource Co.
PXD
|
+$65M |
| 4 |
AL
Air Lease Corp
AL
|
+$32.4M |
| 5 |
Iron Mountain
IRM
|
+$30.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 22.62% |
| 2 | Industrials | 21.5% |
| 3 | Technology | 11.24% |
| 4 | Energy | 10.58% |
| 5 | Consumer Discretionary | 8.99% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
BNY
51
Bank of New York Mellon
BNY
$111B
| $17.6M | 0.5% |
419,226
+1,220
| +0.3% | +$52K |
|
|
VAR
52
DELISTED
Varian Medical Systems, Inc.
VAR
| $17.4M | 0.49% |
235,264
-13,576
| -5% | -$1.06M |
|
53
TJX Companies
TJX
$145B
| $17.3M | 0.49% |
522,364
-1,550
| -0.3% | -$51.5K |
|
54
Labcorp
LH
$26.9B
| $17.2M | 0.49% |
165,612
-104
| -0.1% | -$10.8K |
|
55
Agios Pharmaceuticals
AGIO
$1.98B
| $17.2M | 0.49% |
+154,755
| New | +$16.7M |
|
|
SRCL
56
DELISTED
Stericycle Inc
SRCL
| $16.3M | 0.46% |
121,532
+45,400
| +60% | +$6.22M |
|
57
Kimberly-Clark
KMB
$35.9B
| $16.2M | 0.46% |
152,649
-100
| -0.1% | -$10.9K |
|
58
Fidelity National Information Services
FIS
$21.8B
| $16.1M | 0.46% |
259,982
-700
| -0.3% | -$44.8K |
|
|
AGN.PRA
59
DELISTED
Allergan plc
AGN.PRA
| $15.9M | 0.45% |
+15,166
| New | +$15.9M |
|
60
Blackstone
BX
$103B
| $15.8M | 0.45% |
+394,913
| New | +$16.2M |
|
61
Weyerhaeuser
WY
$16.6B
| $15.5M | 0.44% |
491,947
-434,845
| -47% | -$14M |
|
|
AM
62
DELISTED
ANTERO MIDSTREAM PARTNERS LP
AM
| $15.4M | 0.44% |
538,282
-397,415
| -42% | -$10.7M |
|
63
Deere & Co
DE
$187B
| $15.4M | 0.44% |
158,691
-1,838
| -1% | -$167K |
|
64
Lockheed Martin
LMT
$123B
| $14.5M | 0.41% |
78,214
-395
| -0.5% | -$76.1K |
|
65
Comcast
CMCSA
$94.6B
| $14.4M | 0.41% |
479,234
-3,400
| -0.7% | -$99.8K |
|
66
Berkshire Hathaway Class A
BRK.A
$1.09T
| $13.9M | 0.39% |
68
| – | – |
|
|
ICPT
67
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
| $13.6M | 0.38% |
56,265
+685
| +1% | +$182K |
|
|
SWN
68
DELISTED
Southwestern Energy Company
SWN
| $13.4M | 0.38% |
590,722
+263,210
| +80% | +$6.75M |
|
69
Merck
MRK
$376B
| $13.2M | 0.37% |
242,519
+3,715
| +2% | +$208K |
|
70
Apple
AAPL
$4.79T
| $13.1M | 0.37% |
418,684
-10,740
| -3% | -$344K |
|
71
Home Depot
HD
$317B
| $13.1M | 0.37% |
117,628
+600
| +0.5% | +$67.2K |
|
|
MACK
72
DELISTED
Merrimack Pharmaceuticals, Inc.
MACK
| $13M | 0.37% |
133,605
+90,810
| +212% | +$8.64M |
|
73
Fidelity National Financial
FNF
$12.7B
| $12.6M | 0.36% |
491,515
-1,293
| -0.3% | -$33.4K |
|
74
Franco-Nevada
FNV
$52.1B
| $12.6M | 0.36% |
264,550
+72,650
| +38% | +$3.68M |
|
|
KMI.WS
75
DELISTED
Kinder Morgan Inc
KMI.WS
| $12.5M | 0.35% |
4,613,100
+3,379,350
| +274% | +$13.8M |
|
Similar funds
GW
PMEF
SS
WMSA
GC
WP
BWM
DI
Cannell & Co's Q2 2015 Portfolio in Review
As of Q2 2015, Cannell & Co held 290 positions worth $3.53B, up 2.2% from $3.45B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Cannell & Co deployed $137M of net new capital in Q2 2015, opening 27 new positions and adding to 78 existing holdings. Its largest new stake was Golar LNG: 1,035,540 shares worth $48.5M.
By sector, the portfolio is most concentrated in Healthcare at 23% of assets, up from 21% a quarter earlier, followed by Industrials and Technology.
On the sell side, the largest reduction was Gilead Sciences, an estimated $67.5M trimmed.
- Cannell & Co's largest Q2 2015 buy was Golar LNG: 1,035,540 shares worth $48.5M.
- Cannell & Co added most to Whirlpool in Q2 2015, an estimated $83.4M increase.
- Cannell & Co's biggest Q2 2015 reduction was Gilead Sciences, cutting an estimated $67.5M.
- Cannell & Co fully exited Micron Technology in Q2 2015, selling an estimated $76.6M.
- Cannell & Co's ten largest holdings make up 31% of its $3.53B portfolio in Q2 2015.
- Cannell & Co opened 27 new positions and closed 20 in Q2 2015.
- Cannell & Co's portfolio value rose 2.2% quarter-over-quarter to $3.53B.
Based on Cannell & Co's 13F filing for Q2 2015, filed 13 Aug 2015.